31.30MMarket Cap-889P/E (TTM)
0.3240High0.3020Low340.28KVolume0.3195Open0.3120Pre Close105.66KTurnover0.34%Turnover RatioLossP/E (Static)100.58MShares1.060052wk High-6.22P/B30.78MFloat Cap0.270052wk Low--Dividend TTM98.89MShs Float108.7000Historical High--Div YieldTTM7.05%Amplitude0.2700Historical Low0.3100Avg Price1Lot Size
Dare Bioscience Stock Forum
Update
As an Investor Catalyst Hub spoke, Daré gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spok...
Good news lately give a updated PT
Bioscience Company Secures Massive $22 Million Royalty Financing
Daré Bioscience, a leader in women's health innovation, has announced securing $22 million in non-dilutive strategic royalty financing. This infusion of capital is earmarked for the advancement of its Phase 3 first-in-category product candidates, setting a new pace in the realm of women's health care. $Dare Bioscience(DARE.US)$
https://stockregion.app/p/bioscience-company-secures-massive
Now just need volume!
NEWS
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
Daré Bioscience secured $22 million in non-dilutive strategic royalty financing to advance Phase 3 first-in-category women’s health product candidates through key catalysts. The transaction with XOMA provides significant capital for Daré to focus on advancing Ovaprene® and Sildenafil Cream, 3.6...
WooHoo 6 days later! Hehehe
Benzinga· 1 min ago
Hell yeah
No comment yet